Document Type
Patent
Publication Date
July 2014
Patent Number
8765119
CPC
A61K 35/28(20130101), A61K 35/51(20130101), A61K 2035/124(20130101), A61K 35/50(20130101), A61K 35/30(20130101), A61K 9/0085(20130101), C12N 5/0647(20130101), C12N 5/0663(20130101), C12N 5/0607(20130101), C12N 5/0675(20130101), C12N 2506/11(20130101)
Abstract
A method of treating a patient with a neurodegenerative disease, such as ALS, using progenitor cells isolated from human umbilical cord blood. Non-invasive transplantation of aldehyde dehydrogenase (ALDH+) expressing progenitor cells provides cell replacement and protection of motor neurons.
Application Number
10/908,322
Recommended Citation
Garbuzova-Davis, Svitlana; Balber, Andrew; Davis-Sanberg, Cyndy; Gentry, Tracy; Kuzmin-Nichols, Nicole; Sanberg, Paul R.; and Willing, Alison, "Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells" (2014). USF Patents. 134.
https://digitalcommons.usf.edu/usf_patents/134
Assignees
University of South Florida Saneron CCEL Therapeutics, Inc. StemCo Biomedical, Inc.
Filing Date
05/06/2005
Primary/U.S. Class
424/937
